TLR2 and hepatocellular carcinoma: Another important discovery of these authors was that NAC treatment interrupts the positive feedback of the ROS/ER stress-p62 aggregation-unfolded protein response (UPR)-induced inflammation and backed the TLR2 deficiency increased susceptibility of HCC development and progression.